The largest database of trusted experimental protocols

Measles

Measles is a highly contagious viral disease characterized by a distinctive red rash, fever, and respiratory symptoms.
It is caused by the measles virus, a member of the Paramyxoviridae family.
Measles primarily affects children, but can occur in individuals of any age.
Symptoms typically appear 10-14 days after exposure and include fever, cough, runny nose, red eyes, and a red, blotchy rash that spreads from the face to the rest of the body.
Complications can include pneumonia, encephalitis, and even death, especially in young children.
Vaccination is the most effective way to prevent measles, and two doses of the measles vaccine are recommended for optimal immunity.
Despite the availability of a safe and effective vaccine, measles outbreakes can still occur, particularly in unvaccinatied populations.
Reasearch to improve measles prevention, diagnosis, and treatment remains an important public health priority.

Most cited protocols related to «Measles»

To construct the Healthcare Access and Quality (HAQ) Index, we first rescaled the log age-standardised risk-standardised death rate by cause to a scale of 0 to 100 such that the highest observed value from 1990 to 2015 was 0 and the lowest was 100. To avoid the effects of fluctuating death rates in small populations on rescaling, we excluded populations less than 1 million population from setting minimum and maximum values. Any location with a cause-specific death rate below the minimum or above the maximum from 1990 to 2015 was set to 100 or 0, respectively.
Because each included cause provided some signal on average levels of personal health-care access and quality, we explored four approaches to construct the HAQ Index: PCA, exploratory factor analysis, arithmetic mean, and geometric mean. Details on these four approaches are in the appendix (pp 7, 8, 21, 22). All four measures were highly correlated, with Spearman's rank order correlations exceeding rs=0·98. We selected the PCA-derived HAQ Index because it provided the strongest correlations with six other currently available cross-country measures of access to care or health-system inputs (table 2). Three indicators came from the GBD Study 2015: health expenditure per capita, hospital beds per 1000, and the UHC tracer intervention index, a composite measure of 11 UHC tracer interventions (four childhood vaccinations; skilled birth attendance; coverage of at least one and four antenatal care visits; met need for family planning with modern contraception; tuberculosis case detection rates; insecticide-treated net coverage; and antiretroviral therapy coverage for populations living with HIV).56 (link) Three indicators came from WHO (physicians, nurses, and midwives per 1000),57 the International Labour Organization,46 and the World Bank (coverage index based on diphtheria-pertussis-tetanus vaccine coverage, coverage of at least four antenatal care visits, and proportion of children with diarrhoea receiving appropriate treatment).45 All indicators had correlation coefficients greater than 0·60, and three exceeded 0·80 (health expenditure per capita, the UHC tracer index, and International Labour Organization formal health coverage).

Correlations between different constructions of the HAQ Index and existing indicators of health-care access or quality

Source and yearGeographies representedHAQ Index construction
PCA weightedEFA weightedGeometric meanMean
Health expenditure per capitaGBD 20151950·8840·8800·8540·864
Hospital beds (per 1000)GBD 20151950·7000·6830·6250·650
UHC tracer index of 11 interventionsGBD 20151880·8260·8200·8120·818
Physicians, nurses, and midwives per 1000WHO 2010730·7690·7550·7250·732
Proportion of population with formal health coverageILO 2010–11930·8080·7980·7730·781
Coverage index of three primary health-care interventionsWorld Bank 20151230·6010·5890·5570·570

The universal health coverage tracer index of 11 interventions included coverage of four childhood vaccinations (BCG, measles, three doses of diphtheria-pertussis-tetanus, and three doses of polio vaccines); skilled birth attendance; coverage of at least one and four antenatal care visits; met need for family planning with modern contraception; tuberculosis case detection rates; insecticide-treated net coverage; and antiretroviral therapy coverage for populations living with HIV. The World Bank coverage index included coverage of three interventions: three doses of diphtheria-pertussis-tetanus vaccine; at least four antenatal care visits; and children with diarrhoea receiving appropriate treatment. HAQ Index=Healthcare Access and Quality Index. PCA=principal components analysis. EFA=exploratory factor analysis. GBD=Global Burden of Disease. UHC=universal health coverage. ILO=International Labour Organization.

The appendix (pp 21, 22) provides final rescaled PCA weights derived from the first five components that collectively accounted for more than 80% of the variance in cause-specific measures. Colon and breast cancer had negative PCA weights, which implied higher death rates were associated with better access and quality of care; because this cannot be true we set these weights to zero in the final PCA-derived HAQ Index. The appendix (p 15) compares each geography's HAQ Index in 2015 with the log of its age-standardised risk-standardised mortality rates.
Full text: Click here
Publication 2017
Care, Prenatal Child Childbirth Colon Contraceptive Methods Diarrhea Head Insecticides Malignant Neoplasm of Breast Measles Midwife Nurses Physicians Poliovirus Vaccines Population Group Primary Health Care Quality of Health Care Tuberculosis Vaccination Vaccination Coverage Vaccine, Diphtheria-Pertussis-Tetanus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Adenovirus Infections cDNA Library Communicable Diseases Coronavirus Homo sapiens Human Metapneumovirus Human respiratory syncytial virus Influenza Measles Parainfluenza Respiration Disorders Rhinovirus Severe Acute Respiratory Syndrome Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
African Trypanosomiasis Hepatitis A Leishmaniasis, Visceral Malaria Measles Paratyphoid Fever Pertussis Syphilis Typhoid Fever Yellow Fever Zika Virus Infection

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Acquired Immunodeficiency Syndrome Acute Disease African Trypanosomiasis Appendicitis Behavior Disorders Care, Prenatal Cerebrovascular Accident Child Cholera Chronic Kidney Diseases Congenital Abnormality Dementia Dengue Fever Disease, Chronic Drug Abuser Epilepsy Households Injuries Intellectual Disability Leprosy Liver Cirrhosis Malignant Neoplasms Measles Mental Health Multiple Sclerosis Myocardial Infarction Outpatients Pancreatitis Patient Discharge Patients Pertussis Pneumoconiosis Population Group Projective Techniques Respiratory Diaphragm Schistosomiasis sequels Skin Diseases Syphilis Tuberculosis Vision Woman Yellow Fever
The study definitions reflected national guidelines for management of uncomplicated malaria, which were valid at the time of the study [11 (link)]. In summary, the guidelines recommend that in high malaria risk areas, all children under five years of age with fever or history of fever should be presumptively treated with AL. In low malaria risk areas, presumptive treatment with AL is recommended in all febrile children in the absence of measles, runny nose and other obvious causes of fever. For clinical management purposes, all parts of Kenya were classified as high malaria risk areas, except the highlands of Central and Nairobi provinces. In patients aged five years and older and regardless of the malaria risk, all febrile patients in the absence of another obvious cause of fever should be tested for malaria (microscopy or RDT) and only test positive patients should be treated with AL. In the same age group, presumptive AL treatment is recommended in absence of malaria diagnostics.
Therefore, to reflect criteria for testing and AL treatment, all analyses were restricted to febrile, non-pregnant patients weighing 5 kg and above, presenting for an initial outpatient visit without being referred or admitted for hospitalization. Patients aged five years and older presenting with another obvious cause of fever, as well as the children less than five years of age meeting the same criteria in low risk areas, were excluded from the analysis. Another obvious cause of fever was defined as febrile patients presenting concomitantly with runny nose, sore throat, oral thrush, wounds, urinary problem, skin problem or abscesses. Fever was defined as axillary temperature of ≥37.5°C or a history of fever during the present illness.
To ensure comparable evaluation of anti-malarial treatment practices based on different age-specific recommendations for malaria diagnosis, the focus of the analysis was observations from health facilities where AL was in stock during the survey, stratified by the availability of diagnostics and patients' age (under five and over five years of age). At facilities with malaria diagnostics, anti-malarial treatment practices were further stratified by the use of malaria diagnostic tests and the patient's test result. Combined microscopy and RDT results are presented since the small number of patients with malaria RDTs precluded a meaningful analysis stratified by type of diagnostics.
Data entry and management was undertaken using Access (Microsoft, USA), through customized data entry screens with in-built range and consistency checks. All forms were entered twice by independent data entry clerks and data files were compared for errors using a verification programme and referring to original questionnaires. All analyses were performed using STATA, version 11. The precision of proportions (95% confidence interval [CI]) was determined adjusting for the cluster sampling at the health facility level.
Full text: Click here
Publication 2011
Abscess Age Groups Antimalarials Axilla Child Diagnosis Fever Hospitalization Malaria Measles Microscopy Oral Candidiasis Outpatients Patients Rhabdoid Tumor Rhinorrhea Skin Sore Throat Tests, Diagnostic Urine Wounds

Most recents protocols related to «Measles»

Not available on PMC !

Example 10

Antiviral activity for cytidine analogs
Influenza A
H1N1H3N2H5N1 (low path)Influenza BRSVSARS
EIDD IDStructureEC50EC50EC50EC50EC50EC50
EFVX- 01841[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM70 uM CC50 > 89 uM
EFVX- 01853[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM>100 uM
EFVX- 01854[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM>100 uM
EFVX- 01855[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM>100 uM
EFVX- 01856[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM>100 uM
EFVX- 01857[Figure (not displayed)]
>100 uM>100 uM>100 uM>100 uM>100 uM>87 uM CC50 = 87 uM

MeaslesCHIK VirusDengue VirusRVFVTacaribe VirusVEEVWest Nile Virus
EIDD IDStructureEC50EC50EC50EC50EC50EC50EC50
EFVX-01853[Figure (not displayed)]
>100 uM>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml
EFVX-01854[Figure (not displayed)]
>100 uM>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml
EFVX-01855[Figure (not displayed)]
>100 uM>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml
EFVX-01856[Figure (not displayed)]
>100 uM>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml
EFVX-01857[Figure (not displayed)]
>100 uM>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml>100 ug/ml

Full text: Click here
Patent 2024
Antiviral Agents Cytidine Dengue Fever Infection Influenza Influenza in Birds Measles Nucleosides Nucleotides Pharmaceutical Preparations Severe Acute Respiratory Syndrome Tacaribe virus Viral Structures Virus Physiological Phenomena West Nile virus
We synthesized collections of proximity contact data with varying sensing regimes by downsampling from a baseline. The impact of varying sensing regimes are measured on two types of findings: those regarding network structure, and those involving population-wide disease spread. For the network analyses, we compared network structure with successive levels of downsampling and interpreted the results in terms of classical network models [50 (link)–52 (link)]. For the simulation analyses, we used an individual-level Susceptible-Exposed-Infectious-Recovered (SEIR) model [53 (link)], with reconstructed contact networks using 12 distinct common communicable diseases/pathogens (flu, SARS, fifth, pertussis, measles, chickenpox, MERS, diphtheria, COVID-19 wild type, COVID-19 Alpha variant, COVID-19 Beta variant, COVID-19 Delta variant). We investigated how downsampling (decrements in observation frequency) impacts findings regarding the attack rates, individual infection risks, and outbreak timing from simulation outputs, by employing two distinct downsampling methods named Snapshot and Upperbound. For every combination of choices from downsampling methods, sampling rates, communicable diseases, and studies, the contact network for that study induced by that downsampling rate was derived and analyzed, and simulations conducted using those networks were analyzed.
Full text: Click here
Publication 2023
Chickenpox Communicable Diseases COVID 19 Diphtheria GPER protein, human Infection Measles pathogenesis Pertussis Severe Acute Respiratory Syndrome
Data on 10 notifiable infectious diseases (seasonal influenza, TB, measles, scarlet fever, mumps, rubella, varicella, bacillary dysentery, infectious diarrhea, and HFMD) across China during 2010–2020 were extracted from the China Information System for Disease Control and Prevention (CISDCP). All cases were diagnosed by medical staff with a clinical diagnosis and laboratory tests based on national uniform standards [7 (link)]. Data were aggregated by provincial-level administrative divisions (PLADs) in sex- and age-specific (0–4 years, 5–19 years, 20–24 years, …, ≥ 80 years) monthly time series.
Full text: Click here
Publication 2023
Chickenpox Communicable Diseases Diagnosis Dysentery Dysentery, Bacillary Measles Medical Staff Mumps Rubella Scarlet Fever Virus Vaccine, Influenza
We examined the association between past measles cases and tetanus antibody levels among children participating in the 2013–2014 DRC DHS. Our sample consisted of 711 children 9–59 months old.
Full text: Click here
Publication 2023
Child Immunoglobulins Measles Toxoid, Tetanus
A priori confounders, such as age, sex and geographic location, were included in descriptive and regression analyses. Other potential confounding variables were identified in the literature and based largely on variables representing social determinants of health and found by others to capture health disparities, such as chronic malnutrition (stunting), maternal education, wealth index and birth order.16 ,23 ,24 Malaria status (via blood smear) was included due to its association with host immunosuppression,25 (link) and the authors previously found that rural versus urban residence impacted measles vaccination coverage.26 (link) Finally, due to the history of conflict in the DRC, we created a dichotomous variable of children living in provinces experiencing high levels of conflict versus all other provinces. The 5 (old) provinces (Katanga, Maniema, Nord-Kivu, Orientale and Sud-Kivu) with the highest levels of human displacement in 2014 were classified as provinces experiencing high levels of conflict, as most of the human displacement (97%) was conflict-related.27 ,28 Due to the challenges inherent with directly measuring a household’s wealth, the DHS assumes that the economic state of a household is related to whether the household has access to certain amenities or services. Such variables can easily be included into a questionnaire or directly observed by the interviewer. Within the DHS, households are placed into quintiles according to household ownership of previously selected assets and via principal components analysis. Asset scores are standardized relative to a standard normal distribution and each household receives a summed score based on the standardized score for each asset. Individuals receive a score reflective of their household score, and the resulting quintiles make up the wealth index for the DHS survey.29 In this study, we dichotomized wealth index to compare the most disadvantaged individuals to all others in the sample, resulting in a wealth index that compares the poorest children to all others, or the lowest quintile children to those in the combined group of second lowest, middle, fourth lowest and highest quintile.
Collinearity diagnostic statistics were performed on all explanatory variables included in the final regression models, with acceptable results (tolerance for all variables was ≥ 0.75, variance inflation factor for all variables was ≤ 1.33) for all variables of interest.
Full text: Click here
Publication 2023
BLOOD Child Child Poverty Diagnosis Homo sapiens Households Immune Tolerance Immunosuppression Interviewers Malaria Malnutrition Measles Mothers Vaccination Coverage

Top products related to «Measles»

Sourced in Germany, Canada
Enzygnost is a laboratory equipment product manufactured by Siemens. It is designed for the detection and quantification of specific enzymes in biological samples. The core function of Enzygnost is to provide accurate and reliable analytical results for researchers and healthcare professionals.
Sourced in Germany, United States, United Kingdom, France, Spain, Japan, China, Netherlands, Italy, Australia, Canada, Switzerland, Belgium
The QIAamp Viral RNA Mini Kit is a laboratory equipment designed for the extraction and purification of viral RNA from various sample types. It utilizes a silica-based membrane technology to efficiently capture and isolate viral RNA, which can then be used for downstream applications such as RT-PCR analysis.
Sourced in United States, Austria, Japan, Belgium, Brazil, United Kingdom, Cameroon
SAS software version 9.4 is a comprehensive data analysis and management solution. It provides advanced statistical and analytical capabilities for organizations to manage, analyze, and report on their data. The software includes a range of tools and features to support various data-driven tasks, such as data manipulation, statistical modeling, and predictive analytics.
Sourced in Germany
The Enzygnost® Anti-Measles Virus/IgG is a laboratory diagnostic test used to detect the presence of antibodies against the measles virus in human serum or plasma samples. The test utilizes an enzyme immunoassay (EIA) technique to measure the level of measles-specific IgG antibodies.
Sourced in United States, Denmark, United Kingdom, Canada, Austria
Stata 11 is a comprehensive statistical software package developed by StataCorp. It provides a wide range of data management, analysis, and visualization tools for researchers, students, and professionals across various fields. Stata 11 offers a flexible and user-friendly interface to handle complex data, perform advanced statistical analyses, and generate high-quality reports and graphics.
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in Germany
The Enzygnost® Anti-Rubella Virus/IgM kit is a laboratory diagnostic test used to detect the presence of IgM antibodies specific to the rubella virus. It is an enzyme-linked immunosorbent assay (ELISA) that can be used to aid in the diagnosis of acute rubella infection.
Sourced in Germany
Enzygnost Anti-Measles-Virus/IgM is a lab equipment product designed for the detection of measles virus-specific IgM antibodies in human serum or plasma samples. It is an enzyme immunoassay that can be used as an aid in the diagnosis of measles infection.
Sourced in Germany, Poland
The ELISA kit is a laboratory equipment designed for the detection and quantification of specific analytes in a sample. It utilizes an enzyme-linked immunosorbent assay (ELISA) technique to measure the presence and concentration of target molecules. The kit provides the necessary reagents and procedures to perform this analytical method.

More about "Measles"

Measles is a highly contagious viral disease caused by the measles virus, a member of the Paramyxoviridae family.
It is characterized by a distinctive red rash, fever, and respiratory symptoms.
Measles primarly affects children but can occur in individuals of any age.
Symptoms typically appear 10-14 days after exposure and include fever, cough, runny nose, red eyes, and a red, blotchy rash that spreads from the face to the rest of the body.
Complications from measles can be severe, including pneumonia, encephalitis, and even death, especially in young children.
The Enzygnost® Anti-Measles Virus/IgG and Enzygnost Anti-Measles-Virus/IgM ELISA kits can be used for the serological detection of measles-specific antibodies.
Vaccination is the most effective way to prevent measles.
Two doses of the measles vaccine are recommended for optimal immunity.
However, measles outbreaks can still occur, particularly in unvaccinated populations.
Reasearch to improve measles prevention, diagnosis, and treatment remains an important public health priority.
Tools like the QIAamp Viral RNA Mini Kit can be used to extract viral RNA for diagnostic testing.
Statistical software such as SAS version 9.4, Stata 11, and Stata 13 can be utilized to analyze measles research data.
The Enzygnost® Anti-Rubella Virus/IgM kit can also be used to differentiate between measles and rubella infections.
Despite the availability of effective vaccines and diagnostic tools, measles remains a significant global health concern.
Ongoing research and public health efforts are crucial to further improve measles prevention, early detection, and treatment outcomes.